U2AF2

Splicing factor U2AF 65 kDa subunit · P26368 · U2AF2 on Sugi Atlas →

0 patent compounds predicted against U2AF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to U2AF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Valproate and Levocarnitine in Children With Spinal Muscular Atrophy PHASE3UNKNOWN
Anastrozole or Fulvestrant in Treating Postmenopausal Patients With Breast Cancer PHASE2COMPLETED
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Pumilio1 (PUM1) Expression, Sickle Cell Anemia, β-thalassemia Intermedia nanNOT_YET_RECRUITING
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Molecular Disease Profile of Hematological Malignancies nanUNKNOWN
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
NFC Changes in SLE Patients and Its Correlation With Anti-U1RNPAntibodies and Disease Activity nanUNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Biocollection in MyeloDysplastic Syndrome (P-MDS) nanRECRUITING
Sodium Channel Splicing in Heart Failure Trial nanCOMPLETED
Clinical Manifestations and Biomarkers in Amyotrophic Lateral Sclerosis Type 4 and Other Inherited Neurological Disorders of RNA Processing nanRECRUITING
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
MicroRNA-1 (miRNA-1) and MicroRNA-133a (miRNA-133a) Levels After Acute Exercise in Ultimate Frisbee Athletes nanUNKNOWN
SMN Circular RNAs as Potential Biomarkers for the Therapeutic Response to Nusinersen in Spinal Muscular Atrophy Patients nanUNKNOWN
Becker Muscular Dystrophy - A Natural History Study to Predict Efficacy of Exon Skipping nanUNKNOWN
Micro Ribosomal Nucleic Acid 155 in Non Hodgkin Lymphoma nanCOMPLETED
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes nanRECRUITING
Genetic Factors Affecting the Severity of Beta Thalassemia nanCOMPLETED
Research for Individualized Therapeutics in Rare Genetic Disease nanENROLLING_BY_INVITATION
B3 for NMD: Bench to Bedside and Back nanENROLLING_BY_INVITATION
Clinical Study of Spinal Muscular Atrophy nanCOMPLETED
Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients nanACTIVE_NOT_RECRUITING
Transcriptomes Breast, Ovarian and Leukocyte Hereditary Genes Predisposing to Breast and / or Ovarian Cancer nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a U2AF2 binder may also engage these)

ProteinNameSimilarity
P26369 1.000 P26369 →
Q24562 0.998 Q24562 →
P90727 0.994 P90727 →
P90978 0.993 P90978 →
Q2QKB4 0.993 Q2QKB4 →
Q9ZR40 0.991 Q9ZR40 →
Q9ZR39 0.988 Q9ZR39 →
Q2R0Q1 0.988 Q2R0Q1 →
O23212 0.987 O23212 →
Q8L716 0.986 Q8L716 →
Q2QZL4 0.985 Q2QZL4 →
Q8WN55 0.985 Q8WN55 →
PTBP3 Polypyrimidine tract-binding protein 3 0.984 landscape →
Q91Z31 0.983 Q91Z31 →
Q29099 0.982 Q29099 →
Q5YD48 0.982 Q5YD48 →
Q5R9H4 0.981 Q5R9H4 →
Q923K9 0.981 Q923K9 →
Q8VH51 0.981 Q8VH51 →
Q9UKA9 0.981 Q9UKA9 →
Q66H20 0.980 Q66H20 →
Q91WT8 0.980 Q91WT8 →
Q9LQI9 0.979 Q9LQI9 →
Q9ASP6 0.979 Q9ASP6 →
Q00438 0.978 Q00438 →
PTBP1 Polypyrimidine tract-binding protein 1 0.978 landscape →
RBM39 RNA-binding protein 39 0.978 landscape →
Q9NQ94 0.977 Q9NQ94 →
Q5RC80 0.977 Q5RC80 →
Q9M427 0.977 Q9M427 →